FAPI-42 PET/MR:MRI

Peng Hou1,2, Jie Lv2, Weige Tan3

  • 1Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, 106 Zhongshan 2nd Road, Guangzhou, 510080, China.

概括

-18标记纤维细胞激活蛋白抑制剂42 (18F]FAPI-42) PET/MR通过减少假阳性和改善淋巴结转移检测与标准乳腺MRI相比,显著提高了乳腺癌诊断. 这种先进的成像技术提供了更准确的分期,特别是在具有挑战性的病变.